{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T09:38:57Z","timestamp":1784885937157,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s13555-025-01401-6","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T06:53:02Z","timestamp":1744267982000},"page":"1195-1208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Demographics and Clinical Characteristics among Patients with Distinct Psychosocial Burden Profiles Related to Vitiligo: Results of a Latent Class Analysis"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7201-3324","authenticated-orcid":false,"given":"Kent A.","family":"Hanson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5468-4589","authenticated-orcid":false,"given":"Khaled","family":"Ezzedine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4297-6290","authenticated-orcid":false,"given":"Jenny","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2171-8228","authenticated-orcid":false,"given":"Peter","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0380-0372","authenticated-orcid":false,"given":"Simran","family":"Marwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2392-8111","authenticated-orcid":false,"given":"Samantha K.","family":"Kurosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8944-8421","authenticated-orcid":false,"given":"Roni","family":"Adiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7015-1021","authenticated-orcid":false,"given":"James","family":"Piercy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6111-8008","authenticated-orcid":false,"given":"Ernest H.","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"issue":"6","key":"1401_CR1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1159\/000506103","volume":"236","author":"C Bergqvist","year":"2020","unstructured":"Bergqvist C, Ezzedine K. Vitiligo: a review. Dermatology. 2020;236(6):571\u201392.","journal-title":"Dermatology"},{"issue":"4","key":"1401_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.autrev.2015.12.006","volume":"15","author":"G Iannella","year":"2016","unstructured":"Iannella G, Greco A, Didona D, et\u00a0al. Vitiligo: pathogenesis, clinical variants and treatment approaches. Autoimmun Rev. 2016;15(4):335\u201343.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"1401_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1159\/000528180","volume":"239","author":"R Patel","year":"2023","unstructured":"Patel R, Pandya AG, Sikirica V, et\u00a0al. Prevalence of vitiligo among children and adolescents in the United States. Dermatology. 2023;239(2):227\u201334.","journal-title":"Dermatology"},{"issue":"6","key":"1401_CR4","doi-asserted-by":"publisher","first-page":"e386","DOI":"10.1016\/S2468-2667(24)00026-4","volume":"9","author":"J Akl","year":"2024","unstructured":"Akl J, Lee S, Ju HJ, et\u00a0al. Estimating the burden of vitiligo: a systematic review and modelling study. Lancet Public Health. 2024;9(6):e386\u201396.","journal-title":"Lancet Public Health"},{"issue":"10","key":"1401_CR5","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1111\/jdv.18257","volume":"36","author":"K Bibeau","year":"2022","unstructured":"Bibeau K, Pandya AG, Ezzedine K, et\u00a0al. Vitiligo prevalence and quality of life among adults in Europe, Japan and the USA. J Eur Acad Dermatol Venereol. 2022;36(10):1831\u201344.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"1401_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/jamadermatol.2021.4724","volume":"158","author":"K Gandhi","year":"2022","unstructured":"Gandhi K, Ezzedine K, Anastassopoulos KP, et\u00a0al. Prevalence of vitiligo among adults in the United States. JAMA Dermatol. 2022;158(1):43\u201350.","journal-title":"JAMA Dermatol"},{"issue":"9","key":"1401_CR7","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1111\/jdv.18129","volume":"36","author":"M Picardo","year":"2022","unstructured":"Picardo M, Huggins RH, Jones H, Marino R, Ogunsola M, Seneschal J. The humanistic burden of vitiligo: a systematic literature review of quality-of-life outcomes. J Eur Acad Dermatol Venereol. 2022;36(9):1507\u201323.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"1401_CR8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1365-2133.2008.08678.x","volume":"159","author":"F Sampogna","year":"2008","unstructured":"Sampogna F, Raskovic D, Guerra L, et\u00a0al. Identification of categories at risk for high quality of life impairment in patients with vitiligo. Br J Dermatol. 2008;159(2):351\u20139.","journal-title":"Br J Dermatol"},{"issue":"6","key":"1401_CR9","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/ijd.13198","volume":"55","author":"AA Amer","year":"2016","unstructured":"Amer AA, Gao XH. Quality of life in patients with vitiligo: an analysis of the dermatology life quality index outcome over the past two decades. Int J Dermatol. 2016;55(6):608\u201314.","journal-title":"Int J Dermatol"},{"issue":"4","key":"1401_CR10","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1468-3083.2010.03808.x","volume":"25","author":"KY Wang","year":"2011","unstructured":"Wang KY, Wang KH, Zhang ZP. Health-related quality of life and marital quality of vitiligo patients in China. J Eur Acad Dermatol Venereol. 2011;25(4):429\u201335.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"1401_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1365-2133.2009.09091.x","volume":"161","author":"MA Radtke","year":"2009","unstructured":"Radtke MA, Sch\u00e4fer I, Gajur A, Langenbruch A, Augustin M. Willingness-to-pay and quality of life in patients with vitiligo. Br J Dermatol. 2009;161(1):134\u20139.","journal-title":"Br J Dermatol"},{"issue":"2","key":"1401_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1001\/jamadermatol.2013.927","volume":"149","author":"JI Silverberg","year":"2013","unstructured":"Silverberg JI, Silverberg NB. Association between vitiligo extent and distribution and quality-of-life impairment. JAMA Dermatol. 2013;149(2):159\u201364.","journal-title":"JAMA Dermatol"},{"issue":"3","key":"1401_CR13","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/bjd.15199","volume":"177","author":"YC Lai","year":"2017","unstructured":"Lai YC, Yew YW, Kennedy C, Schwartz RA. Vitiligo and depression: a systematic review and meta-analysis of observational studies. Br J Dermatol. 2017;177(3):708\u201318.","journal-title":"Br J Dermatol"},{"issue":"5","key":"1401_CR14","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/bjd\/ljae020","volume":"190","author":"A Fakih","year":"2024","unstructured":"Fakih A, Tannous R, Lajnef M, et\u00a0al. Stigma in vitiligo: associated factors and severity strata of the Patient Unique Stigmatization Holistic tool in Dermatology (PUSH-D) score. Br J Dermatol. 2024;190(5):712\u20137.","journal-title":"Br J Dermatol"},{"issue":"9","key":"1401_CR15","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.jid.2020.05.079","volume":"140","author":"L Naldi","year":"2020","unstructured":"Naldi L, Cazzaniga S. Research techniques made simple: latent class analysis. J Invest Dermatol. 2020;140(9):1676-80.e1.","journal-title":"J Invest Dermatol"},{"key":"1401_CR16","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.3389\/fpsyg.2019.01214","volume":"10","author":"KJ Petersen","year":"2019","unstructured":"Petersen KJ, Qualter P, Humphrey N. The application of latent class analysis for investigating population child mental health: a systematic review. Front Psychol. 2019;10:1214.","journal-title":"Front Psychol"},{"key":"1401_CR17","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1007\/s13555-023-00997-x","volume":"13","author":"D Tha\u00e7i","year":"2023","unstructured":"Tha\u00e7i D, Tziotzios C, Ito T, et\u00a0al. Hair loss profiles and ritlecitinib efficacy in patients with alopecia areata: post hoc analysis of the ALLEGRO phase 2b\/3 study. Dermatol Ther (Heidelb). 2023;13:2621\u201334.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"11","key":"1401_CR18","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1185\/03007990802457040","volume":"24","author":"P Anderson","year":"2008","unstructured":"Anderson P, Benford M, Harris N, Karavali M, Piercy J. Real-world physician and patient behaviour across countries: Disease-Specific Programmes\u2014A means to understand. Curr Med Res Opin. 2008;24(11):3063\u201372.","journal-title":"Curr Med Res Opin"},{"issue":"12","key":"1401_CR19","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1080\/03007995.2023.2279679","volume":"39","author":"P Anderson","year":"2023","unstructured":"Anderson P, Higgins V, Courcy J, et\u00a0al. Real-world evidence generation from patients, their caregivers and physicians supporting clinical, regulatory and guideline decisions: an update on Disease Specific Programmes. Curr Med Res Opin. 2023;39(12):1707\u201315.","journal-title":"Curr Med Res Opin"},{"key":"1401_CR20","unstructured":"European Pharmaceutical Market Research Association. Code of Conduct. 2022 [cited 2025 Jan 17]. Available from: https:\/\/www.ephmra.org\/sites\/default\/files\/2022-08\/EPHMRA%202022%20Code%20of%20Conduct.pdf."},{"issue":"8","key":"1401_CR21","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1007\/s13555-022-00772-4","volume":"12","author":"H Kitchen","year":"2022","unstructured":"Kitchen H, Gandhi K, Carmichael C, et\u00a0al. A qualitative study to develop and evaluate the content validity of the Vitiligo Patient Priority Outcome (ViPPO) measures. Dermatol Ther (Heidelb). 2022;12(8):1907\u201324.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"5","key":"1401_CR22","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"MC Reilly","year":"1993","unstructured":"Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353\u201365.","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"1401_CR23","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.jaad.2012.01.038","volume":"69","author":"E Lilly","year":"2013","unstructured":"Lilly E, Lu PD, Borovicka JH, et\u00a0al. Development and validation of a Vitiligo-Specific Quality-of-Life instrument (VitiQoL). J Am Acad Dermatol. 2013;69(1):e11\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"1401_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361\u201370.","journal-title":"Acta Psychiatr Scand"},{"issue":"10","key":"1401_CR25","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, et\u00a0al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u201336.","journal-title":"Qual Life Res"},{"issue":"4","key":"1401_CR26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000084751","volume":"210","author":"K Ongenae","year":"2005","unstructured":"Ongenae K, Dierckxsens L, Brochez L, van Geel N, Naeyaert JM. Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage. Dermatology. 2005;210(4):279\u201385.","journal-title":"Dermatology"},{"issue":"5","key":"1401_CR27","doi-asserted-by":"publisher","first-page":"553","DOI":"10.2340\/00015555-1981","volume":"95","author":"C Kr\u00fcger","year":"2015","unstructured":"Kr\u00fcger C, Schallreuter KU. Stigmatisation, avoidance behaviour and difficulties in coping are common among adult patients with vitiligo. Acta Derm Venereol. 2015;95(5):553\u20138.","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"1401_CR28","first-page":"46","volume":"12","author":"MBC Maymone","year":"2019","unstructured":"Maymone MBC, Rajanala S, Widjajahakim R, Secemsky E, Saade D, Vashi NA. Willingness-to-pay and time trade-off: the burden of disease in patients with benign hyperpigmentation. J Clin Aesthet Dermatol. 2019;12(5):46\u20138.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"2","key":"1401_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1348\/135910702169457","volume":"7","author":"AR Thompson","year":"2002","unstructured":"Thompson AR, Kent G, Smith JA. Living with vitiligo: dealing with difference. Br J Health Psychol. 2002;7(2):213\u201325.","journal-title":"Br J Health Psychol"},{"issue":"1","key":"1401_CR30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ijwd.2017.11.005","volume":"4","author":"PE Grimes","year":"2018","unstructured":"Grimes PE, Miller MM. Vitiligo: patient stories, self-esteem, and the psychological burden of disease. Int J Womens Dermatol. 2018;4(1):32\u20137.","journal-title":"Int J Womens Dermatol"},{"issue":"1","key":"1401_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210581","volume":"14","author":"D Chen","year":"2019","unstructured":"Chen D, Tuan H, Zhou EY, Liu D, Zhao Y. Quality of life of adult vitiligo patients using camouflage: a survey in a Chinese vitiligo community. PLoS\u00a0One. 2019;14(1): e0210581.","journal-title":"PLoS\u00a0One"},{"issue":"3","key":"1401_CR32","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1159\/000363407","volume":"229","author":"V Ingordo","year":"2014","unstructured":"Ingordo V, Cazzaniga S, Medri M, et\u00a0al. To what extent is quality of life impaired in vitiligo? A multicenter study on Italian patients using the dermatology life quality index. Dermatology. 2014;229(3):240\u20137.","journal-title":"Dermatology"},{"issue":"1","key":"1401_CR33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/JID.2015.398","volume":"136","author":"C Salzes","year":"2016","unstructured":"Salzes C, Abadie S, Seneschal J, et\u00a0al. The Vitiligo Impact Patient Scale (VIPs): development and validation of a vitiligo burden assessment tool. J Invest Dermatol. 2016;136(1):52\u20138.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"1401_CR34","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jaad.2016.09.034","volume":"76","author":"N van Geel","year":"2017","unstructured":"van Geel N, Lommerts JE, Bekkenk MW, et\u00a0al. Development and validation of a patient-reported outcome measure in vitiligo: the Self Assessment Vitiligo Extent Score (SA-VES). J Am Acad Dermatol. 2017;76(3):464\u201371.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1401_CR35","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/bjd.14208","volume":"174","author":"JM Batchelor","year":"2016","unstructured":"Batchelor JM, Tan W, Tour S, Yong A, Montgomery AA, Thomas KS. Validation of the Vitiligo Noticeability Scale: a patient-reported outcome measure of vitiligo treatment success. Br J Dermatol. 2016;174(2):386\u201394.","journal-title":"Br J Dermatol"},{"issue":"6","key":"1401_CR36","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s13555-024-01187-z","volume":"14","author":"D Rosmarin","year":"2024","unstructured":"Rosmarin D, Soliman AM, Piercy J, Marwaha S, Anderson P, Camp HS. Health-related quality of life burden among adults with vitiligo: relationship to disease severity and disease location. Dermatol Ther (Heidelb). 2024;14(6):1633\u201347.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"2","key":"1401_CR37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11121-011-0201-1","volume":"14","author":"ST Lanza","year":"2013","unstructured":"Lanza ST, Rhoades BL. Latent class analysis: an alternative perspective on subgroup analysis in prevention and treatment. Prev Sci. 2013;14(2):157\u201368.","journal-title":"Prev Sci"},{"issue":"6","key":"1401_CR38","first-page":"18","volume":"2","author":"EH Law","year":"2016","unstructured":"Law EH, Harrington R. A primer on latent class analysis. Value Outcomes Spotlight. 2016;2(6):18\u20139.","journal-title":"Value Outcomes Spotlight"},{"key":"1401_CR39","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.psychres.2018.03.003","volume":"266","author":"CM Ulbricht","year":"2018","unstructured":"Ulbricht CM, Chrysanthopoulou SA, Levin L, Lapane KL. The use of latent class analysis for identifying subtypes of depression: a systematic review. Psychiatry Res. 2018;266:228\u201346.","journal-title":"Psychiatry Res"},{"issue":"7","key":"1401_CR40","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s11882-015-0542-0","volume":"15","author":"R Howard","year":"2015","unstructured":"Howard R, Rattray M, Prosperi M, Custovic A. Distinguishing asthma phenotypes using machine learning approaches. Curr Allergy Asthma Rep. 2015;15(7):38.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"3","key":"1401_CR41","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/bjd\/ljad410","volume":"190","author":"CV Chalitsios","year":"2024","unstructured":"Chalitsios CV, Meena D, Manou M, et\u00a0al. Multiple long-term conditions in people with psoriasis: a latent class and bidirectional Mendelian randomization analysis. Br J Dermatol. 2024;190(3):364\u201373.","journal-title":"Br J Dermatol"},{"issue":"3","key":"1401_CR42","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.027689","volume":"12","author":"R Nakamaru","year":"2023","unstructured":"Nakamaru R, Shiraishi Y, Niimi N, et\u00a0al. Phenotyping of elderly patients with heart failure focused on noncardiac conditions: a latent class analysis from a multicenter registry of patients hospitalized with heart failure. J Am Heart Assoc. 2023;12(3): e027689.","journal-title":"J Am Heart Assoc"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01401-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-025-01401-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01401-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T18:02:29Z","timestamp":1745690549000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-025-01401-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1401"],"URL":"https:\/\/doi.org\/10.1007\/s13555-025-01401-6","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"31 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"K.A. Hanson was a paid consultant for Pfizer during the period in which the work for this manuscript was conducted. K. Ezzedine is a consultant for AbbVie, Incyte, La Roche-Posay, Pfizer, Pierre Fabre, Sanofi, and Viela Bio. J. Austin, P. Anderson, S. Marwaha, and J. Piercy are employees of Adelphi Real World. S.K. Kurosky, R. Adiri, and E.H. Law are employees of and hold stock or stock options in Pfizer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Data were collected according to European Pharmaceutical Marketing Research Association guidelines, and the DSP protocol (21-ADRW-122) was submitted to the Pearl Institutional Review Board and was granted an exemption. Data were collected in full accordance with relevant legislation at the time. Informed consent was obtained from all individual participants included in the study. The manuscript does not include personal details or images that may lead to the identification of participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}